Michael A. London is one of the founding partners in the law firm of Douglas & London. Mr. London, born in New York, New York, is admitted and licensed to practice law in the State of New York and the State of New Jersey, as well. In addition, he is admitted to practice in federal courts in both New York and New Jersey, and is also admitted to the Court of Federal Claims in Washington, D.C. Mr. London has been admitted pro hac vice in over 12 state and federal courts across the country. He obtained a Bachelor of Arts Degree from the University of Miami, in Coral Gables, Florida, and a Juris Doctorate Degree from Brooklyn Law School in New York.
Since obtaining his law degree, Mr. London has devoted his entire career to always representing injury victims, primarily in mass tort settings. Formerly a partner at the Law Offices of Sybil Shainwald, Michael London's practice area in the law has focused on and continues to focus on products liability litigation with an emphasis in pharmaceutical litigation, including litigation concerning the following drugs and medical devices:
Ortho Evra Birth Control Patch
Kugel Hernia Mesh Patch
Vaccines (Hep-b, Hib, DPT, DTaP, Influenza, MMR)
Chorionic Villi Sampling (CVS)
Guidant & Medtronic Defibrillators
Cox-2 Inhibitor drugs (Vioxx/Bextra/Celebrex)
Disetronic H-Tron insulin infusion pumps
Silicone Breast Implants
Diet Drugs (Phen-Fen and Redux)
Telectronics Pace Makers
Cigarettes (nicotine delivery devices)
Mr. London has also been appointed to and served on multiple steering committees and as class counsel. His specific appointments to Court-appointed Plaintiff Steering Committees include: Member and appointment as Vice-chairman of the Plaintiffs' Steering Committee in the In re: Zyprexa Products Liability Litigation, MDL-1596, pending in the United States District Court for the Eastern District of New York; Member of the Plaintiffs' Steering Committee in the In re: Ortho Evra Products Liability Litigation, MDL-1742, as well as special judicial appointment as federal-liaison counsel in that litigation, pending in the United States District Court for the Northern District of Ohio; Member of the Plaintiffs' Steering Committee in the In re Imagitas Inc. Drivers' Privacy Protection Act Litigation, MDL-1828 pending in the United States District Court for the Middle District of Florida; Member of the Plaintiffs' Steering Committee in the In re: Bextra/Celebrex Products Liability Litigation, pending in the New York State Supreme Court; and Member of the Plaintiffs' Steering Committee in the In re: Claims for Vaccine Injuries Resulting in Autism Spectrum Disorder or Similar Neurodevelopment Disorder v. Sec. HHS, pending in the United States Court of Federal Claims.
He also was co-class counsel in a national class action against Colgate Oral Pharmaceuticals for certain forms of toothpaste and oral rinse that contain an ingredient that has been shown to cause pre-cancerous lesions in the mouth. He was appointed to the Objectors' Steering Committee to represent individual smokers with personal injury claims against Liggett & Myers in its proposed class action to settle all of its pending cases which he and others defeated because of its failure to provide adequate compensation to present, future and foreign Class members. He was co-counsel in the first national Thimerosal class action alleging that exposure to Thimerosal in certain vaccines causes autism and other neurological disorders in children, and was thereafter appointed to the Plaintiffs' Steering Committee to litigate these cases before the Court of Federal Claims.
His former pharmaceutical litigation experience included active participation in the silicone breast implant litigation, including both in MDL-926 and in the Dow Corning bankruptcy proceeding, where his former law firm held Steering Committee roles in both forums, and represented all foreign women, including in a global settlement for all foreign women who received silicone beast implants manufactured by companies other than Dow Corning. Mr. London participated in and litigated the Parlodel drug products liability cases from inception through the first trial which resulted in a successful confidential award to the plaintiff's widow and family, and also actively represented injured clients across the country with defective Telectronics pace maker leads, the Dalkon Shield IUD, and the Copper-7 IUD, all to the benefit of his clients.
Most recently in January, 2004, Mr. London and his partner Gary J. Douglas, Esq., secured a $20 million plus verdict for the widow of a former smoker in the first successful personal injury tobacco lawsuit in the State of New York. Mr. London previously served as co-trial counsel in the first two tobacco cases to be tried in the State of New York - both in the year 2000. Mr. London has also been actively involved in prosecution and appellate issues in personal injury tobacco litigation across the country, including in San Francisco, Missouri, Florida, and Massachusetts.
Prior to the protracted tobacco trials in 2000 and 2003/2004, in 1999, Mr. London was co-trial counsel in the very first Norplant products liability trial in the State of New York - and shortly after the verdict in his trial, a national settlement of over $50 million was reached.
In addition, to the above matters, Mr. London has also handled and continues to handle general negligence cases, environmental toxic tort cases, and complex medical malpractice cases in New York State and across the country.
Mr. London is also an active member in the following legal associations: Board of Directors New York State Trial Lawyers Association (NYSTLA); Member American Association of Justice, f/k/a ATLA; Member New York State Bar Association (NYSBA); Member New York County Lawyers Association; and Member the Tobacco Trial Lawyers Association (TTLA). Mr. London has lectured to attorneys on topics such as medical malpractice, jury selection in products liability cases, and jury selection in tobacco cases, and he has also been invited to assist the Brooklyn Law School's Moot Court Trial Team on multiple occasions.
Mr. London has also appeared on CNN, in the New York Times, as well virtually every other local New York paper and many other publications across the country. Additionally, he has written numerous articles for publication in legal journals on such topics of vaccine use, the Learned Intermediary Doctrine, the Harvard University Medical Malpractice Study, jury selection in products liability cases, mercury exposure, youth smoking, and light cigarettes litigation, generally.